Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of IgA nephropathy.

Jun Wada1, Hitoshi Sugiyama, Hirofumi Makino

  • 1Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. junwada@md.okayama-u.ac.jp

Seminars in Nephrology
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Medical Cooperation in the CKD Patients: 10-Year Multicenter Cohort Study.

Journal of personalized medicine·2023
Same author

Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study.

Modern rheumatology·2023
Same author

Association of <i>HLA</i>-<i>class II</i> alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population.

Frontiers in immunology·2023
Same author

Sex differences in risk factors for end-stage kidney disease and death in type 2 diabetes: A retrospective cohort study.

Journal of diabetes·2023
Same author

Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Modern rheumatology·2023
Same author

Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts actin rearrangement necessary for neutrophil extracellular trap formation.

Arthritis research & therapy·2022

Immunoglobulin A (IgA) nephropathy involves immune complex deposition in the kidneys. Genetic and molecular factors, including abnormal IgA1, contribute to its development and progression, necessitating further research for new treatments.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • Immunoglobulin A (IgA) nephropathy is a primary glomerulonephritis defined by IgA deposits in the kidney's mesangium.
  • Clinical presentations range from asymptomatic microhematuria to end-stage renal disease.

Purpose of the Study:

  • To review the multifactorial pathogenesis of IgA nephropathy.
  • To highlight the roles of genetic predisposition, IgA1 abnormalities, and inflammatory mediators.

Main Methods:

  • Literature review of studies on genetic factors (HLA, RAAS, selectins, 6q22-23 linkage).
  • Analysis of research on aberrant IgA1 glycosylation and its link to cytokine expression (IL-6, PDGF, TNF-alpha, TGF-beta1).

Main Results:

Related Experiment Videos

  • Genetic studies suggest a predisposition to IgA nephropathy.
  • Aberrant galactosylation of IgA1 is observed, potentially driving inflammation and glomerular injury through cytokine induction.
  • Conclusions:

    • IgA nephropathy pathogenesis is complex, involving genetic, environmental, and molecular factors.
    • Further research is crucial to fully elucidate mechanisms and develop targeted therapies for IgA nephropathy.